Elicio Therapeutics Inc
NASDAQ:ELTX

Watchlist Manager
Elicio Therapeutics Inc Logo
Elicio Therapeutics Inc
NASDAQ:ELTX
Watchlist
Price: 8.06 USD -2.18% Market Closed
Market Cap: 141m USD

Operating Margin
Elicio Therapeutics Inc

0%
Current
-425%
Average
5.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-42.3m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Elicio Therapeutics Inc
Glance View

Market Cap
139.1m USD
Industry
Pharmaceuticals

Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. The company is headquartered in Boston, Massachusetts and currently employs 3 full-time employees. The company went IPO on 2021-02-05. The firm is engaged in developing a pipeline of immunotherapies for the treatment of cancer and other diseases. The company provides a platform, amphiphile (AMP) that delivers immuno therapeutics directly to the lymph nodes (brain center) of the immune system. The firm's lead product candidate, ELI-002, is being developed to treat cancers driven by kirsten rat sarcoma (KRAS). The company is conducting a Phase I/II clinical trial of ELI-002 (AMPLIFY-201). The firm is also evaluating the use of ELI-004, a universal AMP-modified clinical practice guidelines (CpG) adjuvant to treat or prevent additional diseases. The firm provides anaplastic lymphoma kinase (ALK) program to identify an internal development candidate. The firm conducts assessments for using ELI-004 to induce immune responses targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

ELTX Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-42.3m
/
Revenue
0
What is the Operating Margin of Elicio Therapeutics Inc?

Based on Elicio Therapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top